Avesthagen
Avesthagen pioneers the convergence between food, pharma and population genetics leading to predictive preventive personalized healthcare.
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.5m | Early VC | ||
| Total Funding | 000k | ||
Avesthagen is a pioneering company in the biopharmaceutical sector, focusing on diagnostics, consumer healthcare, and medical foods. The company leverages cutting-edge science and innovation to deliver solutions that integrate food, pharma, and population genetics. Avesthagen serves a diverse range of clients, including healthcare providers, research institutions, and consumers seeking advanced healthcare solutions. Operating in the global healthcare market, Avesthagen's business model revolves around research and development, product commercialization, and strategic partnerships. The company generates revenue through the sale of its biopharmaceutical products, diagnostic tools, and consumer healthcare items. Avesthagen is also known for its environmentally adjusted approaches and its unique directive, The Avestagenome Project, which aims to map the genetic data of the Parsi Zoroastrian community to predict and prevent diseases.
Keywords: biopharmaceuticals, diagnostics, consumer healthcare, medical foods, population genetics, environmental sustainability, innovation, Avestagenome Project, healthcare solutions, research and development.